AGCO Corporation

Sources: Q4 earnings releases for FY2022, FY2023 and FY2025 (8-K Exhibits 99.1), which carry the consolidated statements for FY2021–FY2025. Ratios are analyst-computed on year-end balances.

Income statement

FY2022 SG&A was later re-presented as $1,189.5 million when bad-debt expense was folded in (Q4 2023 release) — both figures are filed. EBITDA = operating income + depreciation + amortization; adjusted EBITDA starts from adjusted operating income and avoids double-counting PTx Trimble amortization already added back.

Revenue CAGR FY2021–FY2025: −2.5% (analyst-computed), reflecting a 29% peak-to-date decline from FY2023 and the removal of ~$0.8–1.0 billion of annual G&P sales.

Commentary — income statement. Three regimes are visible. (1) FY2021–FY2023: pricing power and mix lifted gross margin by 310 basis points to 26.2% and adjusted operating margin to a record 12.0%. (2) FY2024: volumes collapsed (−19.1%), and reported results absorbed a $507.3 million loss on the G&P sale, $369.5 million of impairments (mainly North America goodwill) and $172.7 million of restructuring, producing a reported operating loss while the adjusted margin held at 8.9%. (3) FY2025: sales fell a further 13.5%, yet gross margin rose to 25.5% on mix (parts at 19% of sales, G&P gone) and positive pricing; adjusted margin of 7.7% compares with roughly 4% at the prior trough, per management's "nearly double" comment. Reported FY2025 EPS of $9.75 is flattered by two non-recurring items: a $261.8 million discrete tax benefit from a legal-entity reorganization ($3.51 per share) and a $219.2 million after-tax gain on the TAFE stake ($2.93 per share). Adjusted EPS of $5.28 is the cleaner measure. Interest expense stepped up from $4.6 million to $93.0 million in FY2024 with the PTx Trimble financing.

Balance sheet

Commentary — balance sheet. PTx Trimble reshaped the balance sheet in FY2024: net debt rose from $0.8 billion to $2.0 billion, goodwill and intangibles from $1.6 billion to $2.5 billion, and a $300 million redeemable noncontrolling interest (Trimble's 15%) appeared. FY2025 delevered by $457 million of net debt through record free cash flow and $236.8 million of affiliate-sale proceeds. At June 30, 2026 the position had seasonally reversed: cash $573.4 million, borrowings due within one year $546.7 million, long-term debt $2,180.3 million — net debt of ~$2,154 million — after $347.0 million of buybacks and a $298.8 million inventory build (Q2 2026 release). Deferred tax assets rose to $905.5 million in FY2025 from the reorganization.

Cash flow

Commentary — cash flow. FY2025 free cash flow of $740.2 million was a record and equal to 188% of adjusted net income, driven by $468.5 million released from receivables and inventories and capex cut by 37%. That is a working-capital harvest, not a run-rate: H1 2026 free cash flow was −$347 million versus +$63 million a year earlier as production rose ahead of demand. Management still targets 75–100% conversion for FY2026 and has raised capex guidance to $300–325 million (Q2 2026 call).

Ratios (analyst-computed)

Definitions: ROE and ROA use reported net income over year-end equity and assets. ROIC = adjusted operating income taxed at a notional 25%, over year-end debt plus equity plus redeemable noncontrolling interests. Interest coverage = adjusted operating income / net interest expense. DSO understates true credit exposure because ~$2.1 billion of receivables are sold off-balance-sheet.

Commentary — ratios. Returns have halved from peak (ROIC 21.5% → 8.4%) as the capital base grew by ~$1 billion with PTx Trimble while operating profit fell 55%. Leverage at 1.5x net debt/adjusted EBITDA is comfortable for an investment-grade issuer, but Moody's flagged in April 2025 that debt/EBITDA on its definitions could approach 4x (Investing.com summary of Moody's action). Inventory days are at a five-year high (131.6), consistent with the H1 2026 inventory build to $3,007.1 million.

Management guidance history for FY2026.

In May 2026 management was targeting ~$6.00 of EPS and a 7.5–8.0% margin. Implied H2 2026 (analyst-computed): net sales of ~$5.15–5.25 billion and adjusted EPS of ~$3.13–3.38, of which Q3 is guided at $2.3–2.4 billion and $0.85–0.90 — leaving a Q4 of roughly $2.75–2.95 billion and ~$2.25–2.50, above Q4 2025's $2.17. The year is therefore back-end loaded onto one quarter.

Bull case

1. Structural margin floor. A 7.5–7.7% adjusted margin two years into a downturn, with ~$190 million of savings in the run-rate and $60–70 million more in 2026, supports high-teens incremental margins when volume returns.

2. North American optionality. Sales grew 19.8% in Q2 2026 in a market down 9%; if Fendt share gains persist and tariffs ease or refunds grow, a segment losing ~$110 million a year can swing sharply.

3. Capital return. Portfolio disposals ($260 million TAFE, $190 million AGCO Finance) are being recycled into buybacks; the share count fell from 74.6 million to ~70 million in a year.

Bear case

1. Europe is rolling over. EME, the source of all profit, turned to −4.7% constant-currency growth in Q2 2026 with German demand ~15% below plan; there is no second profit engine to offset it.

2. Earnings and cash quality. H1 2026 free cash flow was −$347 million with inventory at $3.0 billion; FY2026 depends on a strong Q4 and reported EPS has leaned on tax and disposal gains.

3. Valuation and credit. ~20x guided earnings for a cyclical with a negative Moody's outlook, 2027 maturities, a new CFO and continuing buybacks leaves little margin for a further guide-down.

Catalysts and monitorables (next 12 months)

• Dealer inventory in North America moving from just under seven months toward six.

• Federal Circuit ruling on IEEPA refunds and the shape of replacement tariffs.

• Brazil's political and credit environment and combine demand.

• German and French tractor registrations; euro/dollar.

• PTx growth under new leadership; OutRun commercialization.

• Refinancing of the 2027 notes and revolver; rating-agency actions.

• FY2027 guidance in February 2027 and any update to 2029 targets.

• Further finance joint-venture restructurings with Rabobank.

Analyst verdict. AGCO in late 2026 is a better company than at any previous trough and a more concentrated one. The 2024 portfolio surgery removed a low-margin, non-core business, added a precision-ag platform with genuine mixed-fleet differentiation, and — through the TAFE settlement — eliminated a governance conflict that had shadowed the equity for years. The proof is in the numbers: adjusted operating margin of 7.7% on sales 30% below peak, record free cash flow, and net leverage around 1.5x. Management has also become a more disciplined allocator, swapping lumpy special dividends for buybacks funded by non-core disposals.

The concern is dependency. Europe/Middle East produced more than all of FY2025 segment profit; North America and Latin America both lost money in the first half of 2026. The July guidance cut showed how quickly a soft German market and cautious dealers translate into lower group earnings, and the fourth quarter must now deliver nearly 45% of full-year adjusted EPS. First-half cash outflow, a $3.0 billion inventory position and a tariff bill approaching $100 million argue for caution on near-term estimates, while the simultaneous change of CFO and PTx president adds execution risk to the very lever that underpins the 2029 margin ambition.

On balance the evidence supports a neutral stance, consistent with the Street's "Hold" and a consensus target only about 10% above the price. The stock is not cheap on trough earnings, but downside is cushioned by buybacks, cost savings and an eventual replacement cycle. We would turn constructive on evidence that North America can reach breakeven with dealer inventory at target, and that PTx can grow through the downturn; we would turn negative if European order intake deteriorates further or if leverage rises into the 2027 refinancing. The long-term thesis is intact; the next two quarters must show the trough is behind it.

DATA GAPS AND DISCREPANCIES LOG